246 related articles for article (PubMed ID: 37737166)
1. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
[TBL] [Abstract][Full Text] [Related]
2. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
3.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
4. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
[TBL] [Abstract][Full Text] [Related]
5. Radiomic Analysis of Contrast-Enhanced CT Predicts Glypican 3-Positive Hepatocellular Carcinoma.
Sun S; Xiao S; Jiang Z; Xiao J; He Q; Wang M; Fan Y
Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462828
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma.
Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L
Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of Contrast-Enhanced CT-Based Deep Transfer Learning and Combined Clinical-Radiomics Model to Discriminate Thymomas and Thymic Cysts: A Multicenter Study.
Yang Y; Cheng J; Peng Z; Yi L; Lin Z; He A; Jin M; Cui C; Liu Y; Zhong Q; Zuo M
Acad Radiol; 2024 Apr; 31(4):1615-1628. PubMed ID: 37949702
[TBL] [Abstract][Full Text] [Related]
8. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
9. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
[TBL] [Abstract][Full Text] [Related]
10. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
11. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
[TBL] [Abstract][Full Text] [Related]
12. Comparison of MRI and CT for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma Based on a Non-Radiomics and Radiomics Method: Which Imaging Modality Is Better?
Meng XP; Wang YC; Zhou JY; Yu Q; Lu CQ; Xia C; Tang TY; Xu J; Sun K; Xiao W; Ju S
J Magn Reson Imaging; 2021 Aug; 54(2):526-536. PubMed ID: 33622022
[TBL] [Abstract][Full Text] [Related]
13. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
[TBL] [Abstract][Full Text] [Related]
14. Prediction of preoperative microvascular invasion by dynamic radiomic analysis based on contrast-enhanced computed tomography.
Zhou Z; Xia T; Zhang T; Du M; Zhong J; Huang Y; Xuan K; Xu G; Wan Z; Ju S; Xu J
Abdom Radiol (NY); 2024 Feb; 49(2):611-624. PubMed ID: 38051358
[TBL] [Abstract][Full Text] [Related]
15. Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
Li M; Fan Y; You H; Li C; Luo M; Zhou J; Li A; Zhang L; Yu X; Deng W; Zhou J; Zhang D; Zhang Z; Chen H; Xiao Y; Huang B; Wang J
Radiology; 2023 Aug; 308(2):e230255. PubMed ID: 37606573
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features.
Wu H; Han X; Wang Z; Mo L; Liu W; Guo Y; Wei X; Jiang X
Phys Med Biol; 2020 Dec; 65(23):235048. PubMed ID: 32756021
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
18. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
19. [Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma].
Yu YX; Hu CH; Wang XM; Fan YF; Hu MJ; Shi C; Hu S; Zhu M; Zhang Y
Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1239-1245. PubMed ID: 34865392
[No Abstract] [Full Text] [Related]
20. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]